Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 36–36 | Cite as

Antineoplastics

Drug resistance secondary to acquired gene mutation: case report
Case report
  • 26 Downloads

Reference

  1. Yang T, et al. Elevation of tumor mutation burden in ROS1-fusion lung adenocarcinoma resistant to crizotinib: A case report. Medicine 97: e13797, No. 52, Dec 2018. Available from: URL: http://doi.org/10.1097/MD.0000000000013797 - ChinaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations